Home Life Science Seattle-Based Pharma Co. Awarded $74MM DOD Contract for Drug Production
Life Science

Seattle-Based Pharma Co. Awarded $74MM DOD Contract for Drug Production

Share
Share
Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announ

Enter your e-mail to read the full story and to receive our e-mail newsletters.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Or, Subscribe to The Registry and receive full access today. Already a subscriber? Log In to read the rest of this content.
Share

Recent Posts


Recent Posts

Related Articles

Seattle Life Sciences Market Posts Modest Gains as Major Construction Project Completes

Pacific Northwest hub delivers 227,000 square feet of new lab space, accounting...

Alexandria Real Estate Slashes Dividend 45% as Life Science Downturn Forces Strategy Shift

The pioneering life science REIT posts its fifth consecutive quarterly loss while...

Columbia Pacific Advisors Plans 1,193-Unit Mixed-Use Development in Bellevue’s BelRed District

121,041 SQFT lab research facility and seven residential towers proposed for 8.99-acre...

Seattle Life Sciences Market Faces Headwinds Despite Strong Research Foundation

Vacancy rates climb and leasing activity slows in the Pacific Northwest hub,...

Social Media Auto Publish Powered By : XYZScripts.com